One Health Publications

Highlights

Abstract

Strongyloides stercoralis roundworm infection occurs in ≈600 million persons worldwide and is listed by the World Health Organization as a neglected tropical disease. Understanding zoonotic potential is critical, especially in areas where humans, domestic animals, and wildlife interact. We explored cross-species sharing of Strongyloides roundworms by analyzing fecal samples from humans, dogs, and nonhuman primates in the Dzanga-Sangha Protected Areas, Central African Republic. We detected positive samples by quantitative PCR and assessed genetic diversity through amplification of the 18S rRNA HVR-IV region and cox1, followed by high-throughput sequencing. Strongyloides prevalence was high in humans, dogs, and gorillas. S. stercoralis haplotype A roundworm dominated in humans but appeared in dogs and apes, whereas S. fuelleborni roundworm was present in all hosts. Shared species and haplotypes indicated zoonotic transmission. Our findings highlight the need for molecular surveillance and emphasize the role of dogs and nonhuman primates as reservoirs, complicating efforts to control infections in human populations.

Provided by:

Dr. Didier Villate, a French veterinarian and author specializing in poultry and wildlife. He is currently semi-retired and based in the Lombez/Samatan area of the Gers department in France.

villate.didier@wanadoo.fr

and

Translated by Richard Seifman, JD, MBA – View bio

Français

“The One Health Summit will take place in Lyon, France, with the High-Level Summit on 7 April, coinciding with World Health Day.

Hosted by the French Government as one of the flagship events of the G7 French Presidency, the Summit will convene Heads of State and government, international organizations, scientists, civil society, youth and local actors to advance global action on One Health.

The Summit will highlight the interdependence of human, animal, plant and ecosystem health, and the need for coordinated, science-based approaches to address shared health threats. It will showcase the Quadripartite partnership between, FAO, UNEP, WHO and WOAH, as well as the role of the WHO Academy and WHO’s work across country, regional and global levels.

With WHO assuming the Chair of the Quadripartite on 8 April 2026, the Summit represents a key moment to translate political commitment into concrete, multisectoral action on prevention, preparedness, antimicrobial resistance, sustainable food systems and environmental health, helping to build more resilient and equitable health systems for humans, animals and the planet.  …”

More information

About the Summit

One health and protect the future

Integrate the perspectives of human, animal, and environmental health, promote cross-disciplinary teaching, research, and service cooperation, strengthen surveillance and testing, data analysis, and vaccine drug research and development, deepen policy and regulatory research, implement education and promotion, and work together to prevent zoonotic diseases and protect ecological sustainability and national health.

Provided by:

*Day-Yu  Chao, PhD

Professor  and  Director  of  One  Health  Center

https://ohc.nchu.edu.tw/ 

Graduate  Institute  of  Microbiology  and  Public  Health
School  of  Veterinary  Medicine
National  Chung  Hsing  University
Taichung  (40202).
Taiwan,  R.O.C.

Visiting  professor
Institute  Pasteur,  Paris,  France
University  of  Malaya,  KL,  Malaysia

TEL:  886-4-2284-0694
FAX:  886-4-22852186
Email: dychao@nchu.edu.tw

*Dr. Chao  is a prominent Professor and researcher in the Graduate Institute of Microbiology and Public Health at National Chung Hsing University (NCHU) in Taichung, Taiwan. Her work focuses extensively on infectious disease epidemiology and the development of next-generation vaccines. She is listed on Our Supporters – One Health Initiative (scroll down) since February 2025.

Advancing Health Care in Humans, Animals and the Environment

The U.S. Food and Drug Administration (FDA) and the University of Texas Medical Branch at Galveston invite you to the free, hybrid course “Achieving Data Quality and Integrity in Maximum Containment Labs,” April 20-24, 2026. Highlights include One Health framework, hands-on PPE training, expert networking, and a BSL-3/4 pathogen research focus. The course is open to U.S. and international researchers, sponsors, and regulators and covers FDA Good Laboratory Practice compliance and the integration of human, animal, and environmental health topics relevant to supporting the development of medical countermeasures. Register at https://www.utmb.edu/orncs/regulatory-ops/non-clinical-course

On March 5 2026 (04:00 to 05:30 pm CET) , PREZODE will organise the 8^th session of its webinar series; a panel discussion to examine how to define and measure indicators that capture the added-value and impact of zoonotic disease prevention.

The evaluation of zoonotic disease prevention is hampered by a fundamental methodological challenge: when prevention succeeds, no adverse event occurs, making it inherently difficult to quantify impact, secure sustained funding, or build institutional commitment. Developing robust, evidence-based indicators appears critical to making prevention both measurable and investable. Under the title “How can we assess the added value and impact of One Health prevention strategies?”, our webinar will critically examine the technical, institutional, and political barriers that persist even in the presence of well-designed indicator sets, and explore pathways to translating measurement frameworks into effective policy action.

The panel, moderated by Dr. Christina Pettan-Brewer (University of Washington School of Medicine), will bring together Dr. Osman Dar (Africa CDC), Prof. Wanda Markotter (University of Pretoria), and Dr. Marc Leandri (Université Paris Saclay).

REGISTER HERE: https://inrae-fr.zoom.us/webinar/register/WN_LRbkaicwSAm69P79VqD_Sg

More information here: https://prezode-initiative.org/en/how-can-we-assess-the-added-value-and-impact-of-one-health-prevention-strategies/

Provided by:

Elsa LEGER, PhD

elsa.leger@inrae.fr

Global Science Officer – PREZODE Initiative

prezode.org

Direction des Relations Internationales

INRAE centre-siège

147 rue de l’Université
75338 Paris cedex 07
inrae.fr

AND

Prof Dr Christina Pettan-Brewer MV, DVM, MSc, Indigenous CPOH, Global and One Health PhD 

University of Washington School of Medicine Department of Comparative Medicine

Associate  Professor, Researcher and Director of Animal Health Surveillance and Infectious Disease Monitoring Program

Affiliate Professor DEOHS School of Public Health: UW Center for One Health Research

Global One Health USA/Latin America Fulbright Scholar and Ambassador

*Comparative Medicine Expert Advisor: The 3 R’s Collaborative (human and animal health)

https://3rc.org/health-monitoring/

United Nations (UNEP) One Health High Level Expert Nature For Health (N4H) TAG Member  (Chair)

https://nature4health.org/governance/#tag

Editor, CABI ONE HEALTH – One Health Journal Beyond One Oceans Health 

https://www.cabidigitallibrary.org/journal/cabioh

The International Alliance against Health Risks and Wildlife Trade  Steering Committee Member _ https://alliance-health-wildlife.org/about/ 

AVMA USA One Health Experts Group  and One Health Education Subgroup

World Veterinary Association WVA 2020 – present One Health Expert Committee

Senior Editor, Special Edition CABI One Health Journal : Beyond One Oceans Health

https://www.cabidigitallibrary.org/journal/cabioh/special-issues/beyond-one-ocean-health 

PREZODE TAG member and One Health Scientific Advisor (Co-Chair of IWTG): Pandemic Prevention : https://prezode-initiative.org/en/

PREZODE Scientific Steering Committee Member

ABRASUNI Vice President https://abrasuni.com.br/

Founder One Health Brazil, One Health Colombia and One Health Latin America and Caribbean Research Networks

Visiting Professor and Research Collaborator in Latin America, Asia and Africa

“There is no question that the drama unfolding with the ongoing uncertainties surrounding the United States’ tariff regime over the next 150 days, or thereafter, will have consequences that will not be limited to the U.S.

The February 20 Supreme Court ruling striking down President Donald Trump’s IEEPA-based tariffs incurred his fury and led to his announcement of a 15% global tariff. This has enormous implications for the United States, but also for the Global South and Global North. And it needs to be considered in the context of a broader construct, namely the interface of human, animal, and the ecosystem, e.g., One Health.  …”